HETEROGENEOUS IGG SUBCLASS DISTRIBUTION OF ISLET-CELL ANTIBODIES

被引:17
作者
DOZIO, N
BELLONI, C
GIRARDI, AM
GENOVESE, S
SODOYEZ, JC
BOTTAZZO, GF
POZZA, G
BOSI, E
机构
[1] STATE UNIV LIEGE,DEPT EXPTL NUCL MED,B-4000 LIEGE,BELGIUM
[2] UNIV LONDON LONDON HOSP,COLL MED,DEPT IMMUNOL,LONDON E1 2AD,ENGLAND
关键词
D O I
10.1006/jaut.1994.1004
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Islet cell antibodies (ICA)-IgG are the serological marker of type 1 diabetes, an organ-specific autoimmune disease. A proportion of patients also have thyro-gastric autoimmunity, implying a broader humoral autoreactivity in these cases. In order to determine whether this is also reflected within islet cell antibodies (ICA) we examined the ICA-IgG subclass distribution in type 1 diabetic patients with or without associated thyro-gastric autoantibodies. ICA-IgG subclasses were detected by two-step indirect immunofluorescence, using monoclonal antibodies against the four IgG subclasses, in sera from 51 patients with type 1 diabetes and detectable ICA; 31 had no other antibodies (group 1) and 20 had at least one associated thyroid and/or gastric autoantibody (group 2). Our results show that ICA are polyclonal and invariably IgG1. In 48% of patients with type 1 diabetes without associated thyro-gastric autoantibodies, ICA were restricted to IgG1 only. Conversely, only 10% of those with thyro-gastric antibodies had ICA-IgG1 only (P < 0.02), and a larger ICA-IgG subclass recruitment was observed in these patients (P = 0.002). These findings provide evidence of heterogeneity within ICA at the IgG subclass level, with a broader clonal recruitment within this specificity in individuals displaying features of multiple organ autoimmunity. These results support the hypothesis of heterogeneity within the pathogenetic process leading to type 1 diabetes. © 1994 Academic Press, Inc.
引用
收藏
页码:45 / 53
页数:9
相关论文
共 27 条
[1]   GENETIC SUSCEPTIBILITY LINKED TO DR4 HAPLOTYPES IN DIABETES OF TYPE-1A OR ASSOCIATED WITH POLYENDOCRINOPATHIES (TYPE-1B) [J].
BIGNON, JD ;
SEMANA, G ;
BARDET, S ;
CHENEAU, ML ;
MAUGENDRE, D ;
FAUCHET, R ;
MULLER, JY ;
GENETET, B ;
ALLANNIC, A ;
SAI, P .
TISSUE ANTIGENS, 1991, 38 (04) :183-185
[2]   IMMUNOLOGY AND DIABETES WORKSHOPS - REPORT OF THE 2ND INTERNATIONAL WORKSHOP ON THE STANDARDIZATION OF CYTOPLASMIC ISLET CELL ANTIBODIES - SUMMARY OF A WORKSHOP ORGANIZED BY THE IMMUNOLOGY-AND-DIABETES-WORKSHOPS-COMMITTEE, SUPPORTED IN PART BY THE JUVENILE-DIABETES-FOUNDATION-INTERNATIONAL, AND HELD AT THE SCIENCE AT SEA-1987 MEETING IN PERTH, WESTERN-AUSTRALIA, FROM 20-22 JANUARY 1987T [J].
BONIFACIO, E ;
DAWKINS, RL ;
LERNMARK, A .
DIABETOLOGIA, 1987, 30 (04) :273-273
[3]  
BOSI E, 1991, DIABETES NUTR METAB, V4, P319
[4]  
BOSI E, 1993, DIABETES REV, V1, P204
[5]  
BOTTAZZO GF, 1976, LANCET, V2, P800
[6]   ISLET-CELL ANTIBODIES IN DIABETES-MELLITUS WITH AUTOIMMUNE POLY-ENDOCRINE DEFICIENCIES [J].
BOTTAZZO, GF ;
FLORINCH.A ;
DONIACH, D .
LANCET, 1974, 2 (7892) :1279-1283
[7]  
BOTTAZZO GF, 1980, LANCET, V1, P668
[8]  
BOTTAZZO GF, 1978, BRIT MED J, V2, P1235
[9]  
DOZIO N, 1991, CLIN EXP IMMUNOL, V85, P282
[10]   LUPUS AUTOANTIBODIES TARGET RIBOSOMAL P-PROTEINS [J].
ELKON, KB ;
PARNASSA, AP ;
FOSTER, CL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1985, 162 (02) :459-471